Eszopiclone
Product Images NDC 61919-502

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Eszopiclone (NDC 61919-502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Module)

Chemical structure of Eszopiclone showing its fused ring system with nitrogen atoms, chloropyridine, and methylpiperazine moieties. The image depicts the molecular arrangement of this active ingredient used in the ESZOPICLONE product by DIRECT RX.*

FDA Label Image

Image Description (Label 1)

Packaging label for ESZOPICLONE C-IV 1mg tablets by DIRECT RX, containing 60 tablets. The label states it is a generic for LUNESTA, with each tablet containing 1mg eszopiclone. The label includes usage warnings and storage instructions, with batch and expiration information visible.*

FDA Label Image

Image Description (Label 2)

The packaging label for ESZOPICLONE C-IV, a product by DIRECT RX, contains 30 tablets each with 1 mg eszopiclone. The label highlights it as generic for LUNESTA and includes various product details such as NDC 61919-502-30, lot and expiration dates, and storage instructions. It also contains a caution about the drug's effects and proper handling instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.